Risk Assessment for Carotid Atherosclerosis in Asymptomatic Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
Open Access
- 18 July 2025
- journal article
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 20 (1) , 125-136
Abstract
Hana Park, Ji Young Lee, Sungwon Park, Hyo Jeong Lee, Suh Eun Bae, Jaeil Kim, Hye-Sook Chang, Jaewon Choe, Hye Won Park, Ju Hyun Shim. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl250053Keywords
Funding Information
- National Research Foundation of Korea (NRF-2022R1A2C3008956)
- Ministry of Science, ICT and Future Planning (NRF-2022R1A2C3008956)
This publication has 36 references indexed in Scilit:
- The synergistic impact of nonalcoholic fatty liver disease and metabolic syndrome on subclinical atherosclerosisClinical Endocrinology, 2015
- Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver diseaseAtherosclerosis, 2015
- Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐upHepatology, 2014
- Body Composition and Survival in Stable Coronary Heart DiseaseJACC, 2012
- Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysisBMJ, 2011
- Non-invasive assessment of hepatic steatosis: Prospective comparison of the accuracy of imaging examinationsJournal of Hepatology, 2010
- Carotid intima-media thickness and coronary artery calcium score as indications of subclinical atherosclerosis.2009
- Obesity Paradox in Patients with Hypertension and Coronary Artery DiseaseThe American Journal of Medicine, 2007
- Prediction of Clinical Cardiovascular Events With Carotid Intima-Media ThicknessCirculation, 2007
- Nonalcoholic fatty liver disease.1986